WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
Fax: +47 21 07 81 46
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

D DERMATOLOGICALS

Most of the drugs in this group are preparations for topical use. Some few preparations for systemic use with clear dermatological applications, e.g. griseofulvin (antimycotic), retinoids (for treatment of acne) and psoralens and retinoids (for treatment of psoriasis) are classified in this group.

Only oral preparations in ATC group D are given DDDs. Most products in this group are for topical use, and no DDDs are assigned because the amount given per day can vary very much according to the intensity and distribution of the disease. Consumption figures for these dermatological preparations can be expressed in grams of preparations regardless of strength.


D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE

This group comprises products for topical use in skin infections etc.


D06A ANTIBIOTICS FOR TOPICAL USE

This group comprises antibiotics for dermatological use, except

Antibiotics with antimycotic properties - D01A
Combinations with chemotherapeutics - D06C
Combinations with corticosteroids - D07C
Antiinfectives for treatment of acne - D10AF


D06AA Tetracycline and derivatives


Combined preparations, which contain oxytetracycline and other antibiotics, are classified in D06AA03 - oxytetracycline.

D06AX Other antibiotics for topical use

Combined preparations which contain neomycin and other antibiotics (e.g. bacitracin) are classified in D06AX04 - neomycin.

Combined preparations containing bacitracin and chlorhexidine are classified in D06AX05 - bacitracin.

Last updated: 2013-12-19